Canadian Blood and Marrow Transplant Group
Cure Stems From Here
Meetings
9th Biennial CBMTG Conference
300 delegates from Canada and around the world attended the 9th Biennial CBMTG Conference held from June 3 - 6, 2004 in beautiful London, Ontario.
The 9th Biennial CBMTG Conference was made possible thanks to unrestricted educational grants from:
AMGEN Canada Inc.
Novartis
Ortho Biotech
Hoffmann-La Roche Limited
Merck Frosst Canada Ltd.
Fujisawa Canada Inc.
Pfizer Canada Inc.
Gambro Inc.
THERAKOS, a Johnson & Johnson Company
Enzon Pharmaceuticals
Genzyme Canada Inc.
Miltenyi Biotec, Inc.
StemSoft Software Inc.
ESP Pharma
Genesis Bio-Pharmaceuticals
Program
Pre-Conference Sessions
Wednesday, June 2, 2004
8:00 am -12:00 noon FACT Workshop
1:00 pm - 10:00 pm CBMTG Clinical Trials Network Meeting
Day One
Thursday, June 3, 2004
7:30 am Breakfast
8:30 am Welcome
Session I Quality of Life in HSCT
8:45 am The Gift of Life Comes with a Price
John Wingard
9:25 am Illness Intrusiveness and Quality of Life in BMT
Gerald Devins
10:20 am Break
Session II Concurrent Sessions
10:35 am Session A: Laboratory Issues
CBMTG Technologist Committee Update
Mike Halpenny
ISCT Lab Practices Committee
Speaker TBA
Stem Cell Laboratory Technologist-reclassification
Patty Bakkestad-Legare
Open Discussion Session B: Infection
Infection Control in BMT Recipients - hospital and home
Fiona Smaill
The Diagnosis and Management of Central Venous Line Infections
Bill Thompson
West Nile Virus
Speaker TBA
12:00 noon Lunch
Session III Late Effects of HSCT
1:30 pm Psychological Effects of SCT and Practical Approaches to Therapy/Intervention
Mary Elliot
2:15 pm Exercise in post BMT fatigue
James Russell
3:00 pm Break
3:10 pm Late Effects and Quality of Adult Life After Pediatric Marrow Transplantation
Jean Sanders
4:45 pm Executive & Sponsor Reception
(Board of Directors, Executive Committee, Advisory Board, Conference Sponsors and Supporters)
Day Two
Friday, June 4, 2004
7:30 am Breakfast
Session V Concurrent Sessions
9 :00 am
9:25 am
9:50 am Session A: Myeloma
Overview of Transplantation in Multiple Myeloma
Keith Stewart
Multiple myeloma and allogeneic transplantation:where do we stand
Jean Roy
Speaker TBA
Session B: Non-Malignant Indications (Pediatric)
Stem Cell Transplantation in Children with Hemophagocytic Lymphohistiocytosis (HLH): Results of the HLH-94 Study
Jan-Inge Henter
Mesenchymal Stem Cell Transplantation for Skeletal Disorders
Edwin Horwitz
Transplantation & Gene Therapy for Immune Disorders
Marina Cavazzana-Calvo
10:20 am Break
Session VI Cord Blood and Mesenchymal Stem Cells
10:30 am - 12:00 noon Speakers TBA
12:00 noon Lunch
Session VII Stem Cell Plasticity
2:00 pm - 3:20 pm Speakers TBA
3:20 pm Break
Session VIII Research, Education & Program Development Presentations
3:30 pm - 4:30 pm Presentations from selected abstracts
Session IX Poster Presentations
4:30 pm
Day Three
Saturday, June 5, 2004
7:30 am Breakfast
Session X Non-Hodgkin's Lymphoma and Immunotherapy
9:00 am Ralph Meyer
9:30 am - 10:20 am Speakers TBA
10:20 am Break
Session XI Transplantation of Hodgkin's Lymphoma
10:35 am Results from Autologous Transplantation
Donna Hogge
11:10 am Allogeneic Transplantion
James Russell
11:45 am Lunch
Session XII Graft versus Host Disease and HLA Typing
1:30 pm - 2:50 pm Speakers TBA
2:50 pm Break
Session XIII Acute Leukemia, Meta-Analysis of Bone Marrow vs. Peripheral Blood Allogeneic Trials
3:05 pm - 4:25 pm Speakers TBA
4:25 pm Closing remarks
Kang Howson-Jan and Irwin Walker
5:00 pm CBMTG Annual Business Meeting
7:00 pm Gala Dinner
